Literature DB >> 9125578

Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro.

M Feldmesser1, A Casadevall, Y Kress, G Spira, A Orlofsky.   

Abstract

Eosinophils are components of inflammatory responses to a variety of pathogens. Although a variety of beneficial and harmful functions have been ascribed to these cells, their role in protection against infectious agents remains uncertain. Previous studies have reported eosinophilic pneumonia in mice infected intratracheally with Cryptococcus neoformans. We confirmed this observation and studied the inflammatory response in the lung at day 14 by light and electron microscopy. Immunostaining for glucuronoxylomannan showed isolated cryptococci inside the eosinophilic cuffs. Eosinophils were found to be in close association with C. neoformans in vivo. Cryptococci were associated with eosinophils within eosinophilic perivascular cuffs, within granulomas, and lining the alveolar space. To further investigate this phenomenon in vitro, we isolated rat peritoneal eosinophils and studied cryptococcus-eosinophil interactions in the presence and absence of anti-capsular immunoglobulin G1 (IgG1) and IgE monoclonal antibody (MAb). Eosinophils phagocytosed C. neoformans only in the presence of specific antibody. Phagocytosis was rapid, and dense rings that appeared to consist of granule contents were formed around the organisms. Mast cells were observed to occasionally phagocytose C. neoformans in vitro in the presence of IgE MAb. Our observations suggest that eosinophils may be effector cells against C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125578      PMCID: PMC175238          DOI: 10.1128/iai.65.5.1899-1907.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  74 in total

1.  Helminthotoxic responses of intestinal eosinophils to Trichinella spiralis newborn larvae.

Authors:  T D Lee
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  XII. Blastomycosis of the Spine: Double Lesion: Two Operations: Recovery.

Authors:  G E Brewer; F C Wood
Journal:  Ann Surg       Date:  1908-12       Impact factor: 12.969

3.  Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.

Authors:  A Casadevall; J Mukherjee; S J Devi; R Schneerson; J B Robbins; M D Scharff
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

4.  Pleural effusion secondary to pulmonary cryptococcosis.

Authors:  R Epstein; R Cole; K K Hunt
Journal:  Chest       Date:  1972-03       Impact factor: 9.410

5.  Phagocytosis of bacteria by eosinophils in infectious-related asthma.

Authors:  S G Cohen; T M Sapp
Journal:  J Allergy       Date:  1969-08

6.  Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.

Authors:  A R Anwar; S R Smithers; A B Kay
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

7.  Characterization of the interaction of human eosinophils and neutrophils with opsonized particles.

Authors:  M Yazdanbakhsh; C M Eckmann; D Roos
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

8.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

9.  Eosinophil granule lysis in vitro induced by soluble antigen-antibody complexes.

Authors:  G T Archer; M Nelson; J Johnston
Journal:  Immunology       Date:  1969-11       Impact factor: 7.397

10.  Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils.

Authors:  S Takanaski; R Nonaka; Z Xing; P O'Byrne; J Dolovich; M Jordana
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  29 in total

1.  Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.

Authors:  Marcio L Rodrigues; Leonardo Nimrichter; Débora L Oliveira; Susana Frases; Kildare Miranda; Oscar Zaragoza; Mauricio Alvarez; Antonio Nakouzi; Marta Feldmesser; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2006-11-17

2.  Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4(+) and CD8(+) T cells with a T-helper 1 profile.

Authors:  Ana P Garro; Laura S Chiapello; José L Baronetti; Diana T Masih
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

Review 3.  Innate host defenses against Cryptococcus neoformans.

Authors:  Camaron Hole; Floyd L Wormley
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

4.  Different Lymphocyte Populations Direct Dichotomous Eosinophil or Neutrophil Responses to Pulmonary Cryptococcus Infection.

Authors:  Darin L Wiesner; Kyle D Smith; Sakeen W Kashem; Paul R Bohjanen; Kirsten Nielsen
Journal:  J Immunol       Date:  2017-01-09       Impact factor: 5.422

5.  Susceptibilities of Cryptococcus neoformans strains to platelet binding in vivo and to the fungicidal activity of thrombin-induced platelet microbicidal proteins in vitro.

Authors:  S Nail; R Robert; F Dromer; A Marot-Leblond; J M Senet
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 6.  The intracellular life of Cryptococcus neoformans.

Authors:  Carolina Coelho; Anamelia L Bocca; Arturo Casadevall
Journal:  Annu Rev Pathol       Date:  2013-09-16       Impact factor: 23.472

7.  Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells.

Authors:  Johanna Rivera; Oscar Zaragoza; Arturo Casadevall
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

8.  Intracellular crystal formation as a mechanism of cytotoxicity in murine pulmonary Cryptococcus neoformans infection.

Authors:  M Feldmesser; Y Kress; A Casadevall
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

9.  The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease.

Authors:  Solange Corrêa Garcia Pires d'Avila; Carla Pagliari; Maria Irma Seixas Duarte
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

10.  DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans.

Authors:  Lena J Heung; Tobias M Hohl
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.